MilliporeSigma, the Life Science business of Merck KGaA in the U.S. and Canada, has announced a definitive agreement to acquire HUB Organoids Holding B.V. (HUB). This acquisition marks a significant step forward in enhancing their 2D and 3D cell culture portfolio with the innovative technology of
The pharmaceutical and biotechnology sectors are witnessing a whirlwind of significant developments, from legal disputes over acquisition terms to pivotal personnel changes and strategic restructuring initiatives. These shifts are emblematic of an industry in constant evolution, driven by
The Europe Plant Cell Culture Equipment Market is poised for significant growth from 2024 to 2031. This article delves into the various facets of this burgeoning market, providing a comprehensive analysis that includes market dynamics, product segmentation, regional insights, competitive landscape,
Newcells Biotech, a leading partner in drug discovery recognized for its development of in vitro models and custom assay services, has recently announced a significant milestone by securing an additional £1.2 million in funding from its current investors, including Mercia Ventures, Northstar
Laboratory automation is transforming the healthcare sector by enhancing precision, efficiency, and scalability in diagnostic and research processes. As the need to reduce human error and improve accuracy grows, the demand for advanced technological solutions continues to rise. Additionally, an
The upstream bioprocessing market is experiencing unprecedented growth, driven by a confluence of factors that are reshaping the landscape of biopharmaceutical production. Valued at 22.79 billion USD in 2023, the market is projected to surge to 82.10 billion USD by 2032, expanding at a compound
